https://www.nextbiotech.com.au/asx-...ide-in-duchenne-muscular-dystrophy-treatment/
Anyone know much about this ‘next’ group? I’m trying to figure out what is driving all these biotech’s popping and under ANP I found that these guys seem to be a bit of a catalyst. PYC isn’t in trials of course but is potentially in the DMD space so might be relevant? ANP was tiny so an easy target to pop. Just trying to figure out if this is sector wide for spec bio’s in which case PYC could be 5-6c pretty quickly or stock specific.
https://www.nextbiotech.com.au/asx-juniors-flagship-immunomodulat...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204320 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4333 | 2 |
View Market Depth
| Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |